Obalon Therapeutics to Raise $10 Million in Private

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
53
Obalon Therapeutics to Raise $10 Million in Private Placement

SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it has entered into an agreement to sell shares of its common stock for aggregate gross proceeds of $10 million in a private placement. Investors in the offering included certain unaffiliated institutional investors, members of the Company’s management team and the board of directors and certain of their affiliated funds, including Domain Associates and InterWest Partners.

Obalon Therapeutics will sell approximately 5.5 million shares of common stock at a price of $1.82 per share. The private placement is expected to close on or about August 27, 2018 and is subject to customary closing conditions. The company plans to use the proceeds from the private placement for commercial operations, working capital and general corporate purposes.

The securities to be sold in this private placement have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws, and will be sold in a private placement pursuant to an exemption from the registration requirements of the Securities Act. The securities may not be offered or sold in the United States absent registration or pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws. Obalon Therapeutics has agreed to file a registration statement covering the resale of the shares of common stock acquired by the investors.  

This release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such jurisdiction.

About Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc. (NASDAQ: OBLN ) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. The Obalon Therapeutics management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit www.obalon.com .

Forward-Looking Statements

To the extent that statements contained in this press release are not descriptions of historical facts regarding Obalon Therapeutics, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor of the Private Securities Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties that could cause Obalon Therapeutics' future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the product research and development process and risks and uncertainties related to market conditions and the satisfaction of customary closing conditions related to the private placement. Obalon Therapeutics undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Obalon Therapeutics' business in general, please refer to Obalon Therapeutics’ quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 2, 2018, and its current and future periodic reports filed with the Securities and Exchange Commission.

Contact

Investor Contact:

William Plovanic

Chief Financial Officer

Obalon Therapeutics, Inc.

Office: +1 760.607.5103

wplovanic@obalon.com

Media:

Megan Driscoll

EvolveMKD

Office: +1 646.517.4220

mdriscoll@evolvemkd.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 154

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading
FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 34

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 93

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 114

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Hagerty's Fifth Film Win Keeps Its Media Engine Humming

Updated Category News Views 90

A lap record, a camera crew, and five straight trophies make a louder statement than another glossy corporate slogan. Hagerty won Best Journalism Film at the 2026 International Motor Film Awards on Nov. 14, held at the Petersen Automotive Museum in Los Angeles. The company has taken that particular award home five years running, powered again by Jason Cammisa and his...

Continue Reading
Mar-Jac's Safety Milestone Carries Real Operational Weight

Updated Category News Views 100

Four million worked hours without a lost-time accident is the sort of number that ought to make people pause, especially in poultry processing. Mar-Jac Poultry’s Gainesville facility earned Workplace Safety recognition from the Greater Hall Chamber of Commerce after reaching that mark, and this is one corporate achievement that deserves a little less eye-rolling than...

Continue Reading
Tactical Tomahawk Motor Deal Puts Propulsion in Focus

Updated Category News Views 299

A missile program lives or dies on unglamorous hardware, and solid rocket motors are about as unglamorous as it gets until somebody cannot build enough of them. Raytheon has awarded Ursa Major and Avio USA a joint contract to develop solid rocket motors for the U.S. Navy’s Tactical Tomahawk missile program. That is the whole headline, and it matters more than the thin...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 74

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 59

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Physiatry or Orthopedics: Sorting Out Pain Care Choices

Updated Category News Views 47

Pain care gets muddled the minute people assume every ache needs the same doorway. Dr. Mala Young, a physical medicine and rehabilitation expert in Ann Arbor, Michigan, makes a useful distinction: a physiatrist and an orthopedic doctor may both see pain, mobility trouble, and injury, but they are not interchangeable. That sounds obvious until someone is staring at back...

Continue Reading

Top 5 Most Recently Viewed Articles

Hearth Market Expected to Surpass $14 Billion by 2032

Updated Category News Views 148

Overview of the Hearth Market Recent studies predict that the hearth market value will ascend from USD 9.70 billion in 2023 to an impressive USD 14.14 billion by 2032. This growth reflects a steady compound annual growth rate (CAGR) of 4.3% during this timeframe. The importance of hearths, commonly defined as the floor area in front of a fireplace, extends beyond mere...

Continue Reading
Understanding the IRS's Authority Over Email Seizures

Updated Category News Views 304

The IRS and Electronic Data Seizures In the modern era, questions of privacy and government oversight of electronic communications are more pressing than ever. Specifically, the IRS has a particular framework guiding how it obtains access to electronic records, often bypassing traditional warrant processes. However, the requirement for a search warrant remains intact when...

Continue Reading
United Microelectronics: Insights on Upcoming Earnings Release

Updated Category News Views 130

Upcoming Earnings Report for United Microelectronics United Microelectronics UMC is gearing up for its latest quarterly earnings report. Investors are eager to learn about the company’s financial performance and projections during this critical period. Analysts have made their projections clear, estimating that United Microelectronics will report an earnings per share...

Continue Reading
Stitch Fix Reports Financial Results for Fiscal Year 2025

Updated Category News Views 465

Stitch Fix's Fiscal Year 2025 Financial Overview Stitch Fix, Inc. (NASDAQ: SFIX), the foremost online personal styling service, recently released its financial results for the fiscal year 2025. The performance for Q4 2025 indicates a decrease in net revenue of 2.6% year-over-year; however, there was a 4.4% increase on an adjusted basis that corrects for the extra week in...

Continue Reading
Freight Technologies Unveils Innovative Approach to Crypto Treasury

Updated Category News Views 137

Freight Technologies Makes Bold Steps in Digital Assets Freight Technologies, Inc. (Nasdaq: FRGT), a leading logistics management innovation company, has recently taken significant measures to enhance its digital asset strategy. The company is tapping into the rapidly evolving cryptocurrency market by securing up to USD $20 million through convertible notes. This funding...

Continue Reading